1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZER1 CTRPv2 pan-cancer AAC -0.17 9e-06
mRNA GOLGA2 CTRPv2 pan-cancer AAC -0.17 3e-05
mRNA TIMP2 CTRPv2 pan-cancer AAC -0.17 0.0002
mRNA YIPF2 CTRPv2 pan-cancer AAC -0.17 7e-06
mRNA SLIT3 CTRPv2 pan-cancer AAC -0.17 0.0001
mRNA KLC3 CTRPv2 pan-cancer AAC -0.17 0.0001
mRNA ABHD12 CTRPv2 pan-cancer AAC -0.16 6e-05
mRNA SERINC3 CTRPv2 pan-cancer AAC -0.16 3e-05
mRNA CREBRF CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA ANKRD6 CTRPv2 pan-cancer AAC -0.16 2e-05
Download CSV